Insurance Australia Group (IAG), one of Australia's largest insurers, has agreed to settle a lawsuit brought by Credit Suisse related to the collapse of supply-chain lender Greensill Capital. The settlement covers claims totaling about A$2.8 billion plus interest, according to the company. IAG said the deal will not materially affect its 2027 financial results.
Background: The Greensill collapse
The dispute stems from trade-credit insurance policies written by IAG's BCC Trade Credit unit for entities linked to Greensill. Greensill, which specialized in supply-chain finance—a form of lending where companies borrow against their unpaid invoices—collapsed in 2021 after its business model unraveled. That failure sent shockwaves through global markets, forcing Credit Suisse to shut down about $10 billion in related investment funds and leaving insurers and other parties to fight over who owed what.
Trade-credit insurance protects sellers against the risk that buyers fail to pay. In Greensill's case, IAG's unit had provided such coverage for some of the lender's clients. When Greensill went under, Credit Suisse—which had marketed funds tied to Greensill's loans—sought to recover losses from the insurers, arguing the policies should cover the defaults.
The settlement brings a degree of closure to a long-running legal battle that has been closely watched by the insurance and banking industries. For IAG, the agreement removes a significant overhang of uncertainty, even though the financial hit will be spread over time.
What it means for investors
For IAG shareholders, the key takeaway is that the settlement is large but manageable. The company explicitly stated it won't materially affect its 2027 results, suggesting the payments are structured in a way that avoids a sudden drain on capital. That's a reassuring signal for investors who might have worried about a bigger, more immediate impact.
Still, the A$2.8 billion figure is substantial—roughly equivalent to a year's worth of IAG's net profit in recent periods. The fact that IAG can absorb it without a major hit to future results reflects the insurer's overall financial strength, but it also underscores the risks inherent in writing niche insurance products like trade credit.
For everyday investors, this case is a reminder that insurance companies can face large, unexpected claims that take years to resolve. While IAG's settlement is a specific event, it highlights why insurers hold large capital buffers and why their earnings can be volatile when big claims emerge.
Broader context: The private credit and insurance landscape
The Greensill saga also cast a spotlight on the broader world of private credit and supply-chain finance, areas that have grown rapidly in recent years. Similar concerns have surfaced in other parts of the market, with investors closely watching redemption queues at private credit funds and the ability of lenders to manage risk. For example, Ares Private Credit Fund saw redemption requests ease in Q3, and Apollo's private credit redemption queue has started to move, indicating that stress in that sector may be slowly normalizing.
For insurers, the Greensill case serves as a cautionary tale about the risks of underwriting policies for complex financial products. It also shows how interconnected the insurance and banking worlds can be—a failure in one corner can ripple across both.
What to watch next
Investors will likely focus on the details of the settlement, including how IAG plans to fund the payments and whether any further claims could arise. The company has said the deal won't materially affect 2027 results, but the exact timing of cash outflows remains to be seen.
Also worth watching is whether other insurers involved in similar Greensill-related disputes follow IAG's lead and settle. A wave of settlements could bring more clarity to the industry, but it could also mean additional costs for other firms.
For now, IAG's move appears to be a pragmatic step to put a difficult chapter behind it. As the company moves forward, its focus will likely return to its core insurance operations and the broader Australian market, where competition and regulatory pressures remain key themes.
